Aspira Pathlab & Diagnostics Limited informed that Board of Directors of the Company, at their meeting held on November 12, 2022, considered and approved the change in Designation of Mr. Arvind Bhanushali from Executive Director to Non-Executive Director on the Board of the Company with effect from November 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.84 INR | +1.21% | +9.00% | -18.73% |
28/05 | Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
03/04 | Aspira Pathlab Forms New Limited Liability Partnership | MT |
1st Jan change | Capi. | |
---|---|---|
-18.73% | 3.9M | |
-25.06% | 7.76B | |
+67.56% | 4.35B | |
+2.59% | 2.67B | |
-2.45% | 2.64B | |
-47.56% | 2.1B | |
-17.86% | 1.73B | |
-19.62% | 1.52B | |
+12.59% | 1.18B | |
-45.36% | 1.11B |
- Stock Market
- Equities
- ASPIRA Stock
- News Aspira Pathlab & Diagnostics Limited
- Aspira Pathlab & Diagnostics Limited Approves the Change in Designation of Arvind Bhanushali from Executive Director to Non-Executive Director